wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

DFT-MEDICINE D2-09/10/2025-MAXEMO

Total questions: 10

Worksheet time: 8mins

Name
Class
Date
1.

A patient presents with lethargy and confusion. The examination reveals coarse, dry skin, periorbital puffiness, and a markedly delayed relaxation phase of the ankle jerk reflex. Laboratory investigations show a serum sodium of 124 mEq/L. Which hormonal profile is the most likely underlying cause?

a)

Elevated TSH, decreased free T4

b)

Decreased ACTH, decreased cortisol

c)

Elevated ADH, normal serum cortisol

d)

Elevated aldosterone, decreased renin

2.

The extrathyroidal manifestations of Graves' disease, such as infiltrative ophthalmopathy and pretibial myxedema, are primarily caused by TSH receptor-stimulating autoantibodies targeting which specific cell type in these tissues?

a)

Fibroblasts

b)

Keratinocytes

c)

Endothelial cells

d)

Langerhans cells

3.

The characteristic non-pitting edema of pretibial myxedema and the proptosis seen in Graves' orbitopathy are both initiated by the same underlying mechanism. Which molecular pathway is central to this shared pathophysiology?

a)

TSH receptor antibody stimulation of fibroblasts leading to glycosaminoglycan deposition

b)

Thyroid hormone-mediated increase in systemic beta-adrenergic receptor sensitivity

c)

Type IV hypersensitivity reaction targeting dermal and retro-orbital collagen

d)

Direct infiltration of orbital and dermal tissue by activated T-lymphocytes

4.

A patient presents with progressive dysphagia and a non-tender, diffusely enlarged thyroid gland. On palpation, the gland is 'stony-hard' and feels fixed to adjacent structures. Thyroid function tests are normal. This clinical picture is most characteristic of which condition?

a)

Riedel's thyroiditis

b)

Anaplastic carcinoma

c)

Hashimoto's thyroiditis

d)

Acute suppurative thyroiditis

5.

A non-obese patient diagnosed with diabetes shows an unusually sensitive glycemic response to low-dose sulfonylurea therapy. A detailed history reveals that multiple family members across three generations were diagnosed with non-obese diabetes. This clinical picture is most characteristic of a mutation in which gene?

a)

HNF1A

b)

GCK

c)

HLA-DQA1

d)

INS

6.

A patient with type 2 diabetes and a history of symptomatic heart failure with reduced ejection fraction requires intensification of their glycemic therapy. Based on the predominant mechanism of adverse effects, which of the following drugs is contraindicated?

a)

Pioglitazone

b)

Empagliflozin

c)

Liraglutide

d)

Acarbose

7.

A patient in diabetic ketoacidosis (DKA) is started on an intravenous regular insulin infusion. His initial serum potassium was 5.6 mEq/L. A repeat lab draw 3 hours later shows a potassium of 3.4 mEq/L. This change is primarily due to insulin's direct stimulation of which of the following?

a)

Na+/K+-ATPase pump

b)

Renal Outer Medullary Potassium (ROMK) channels

c)

Na+/H+ antiporter

d)

H+/K+-ATPase pump

8.

A patient with type 2 diabetes and end-stage renal disease on hemodialysis has poorly controlled blood sugars on home monitoring. However, their HbA1c is consistently in the low-normal range. Which of the following markers would provide a more accurate assessment of glycemic control over the preceding 2-3 weeks in this patient?

a)

Serum fructosamine

b)

Repeat HbA1c measurement

c)

1,5-Anhydroglucitol

d)

Serum C-peptide

9.

The patient in the scenario presents with severe metabolic acidosis (HCO3- 10 mEq/L) and ketonemia. In the absence of insulin, which hormone's unopposed action on the liver is the primary driver for the conversion of free fatty acids into ketone bodies?

a)

Glucagon

b)

Cortisol

c)

Epinephrine

d)

Growth Hormone

10.

A 68-year-old male with a 20-year history of poorly controlled Type 2 Diabetes Mellitus presents with an HbA1c of 8.9%. His recent lab work reveals an estimated GFR (eGFR) of 25 mL/min/1.73m², and he is scheduled to begin hemodialysis next month. His current medications include metformin and glimepiride. Which of the following oral hypoglycemic agents can be initiated without the need for dose adjustment?

a)

Linagliptin

b)

Glipizide

c)

Sitagliptin

d)

Insulin Aspart